Chlamydial infection during trachoma monitoring: Are the most difficult-to-reach children more likely to be infected?

Tropical Medicine and International Health

Volumn 17, Issue 3, 2012, Pages 392-396

  Keenan, Jeremy D ^a,b   Moncada, J ^b   Gebre, T ^c   Ayele, B ^c   Chen, M C ^a,b   Yu, S N ^a   Emerson, P M ^c   Stoller, N E ^a   Mcculloch, C E ^b   Gaynor, B D ^a,b   Schachter, J ^a,b  

^a Francis I Proctor Foundation   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CARTER CENTER   (United States)

Author keywords

Chlamydia; Neglected; RNA; Sampling bias

Indexed keywords

AZITHROMYCIN; BACTERIAL RNA;

BACTERIAL DISEASE; CHILD HEALTH; COHORT ANALYSIS; INFECTIOUS DISEASE; RNA; SAMPLING;

ARTICLE; CHILD; CHLAMYDIA; CLINICAL ASSESSMENT; COMMUNITY; CONJUNCTIVA; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; ETHIOPIA; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NEWBORN; POPULATION DISTRIBUTION; PRESCHOOL CHILD; SCHOOL CHILD; SMEAR; TRACHOMA;

AZITHROMYCIN; CHLAMYDIA TRACHOMATIS; CONJUNCTIVA; DELIVERY OF HEALTH CARE; HEALTH SERVICES ACCESSIBILITY; HUMANS; ODDS RATIO; POPULATION SURVEILLANCE; RESIDENCE CHARACTERISTICS; TRACHOMA;

ETHIOPIA;

CHLAMYDIA;

EID: 84857358437     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2011.02919.x     Document Type: Article

References (19)

1. Bowman RJ, Faal H, Jatta B et al. (2002) Longitudinal study of trachomatous trichiasis in The Gambia: barriers to acceptance of surgery. Investigative Ophthalmology & Visual Science 43, 936-940.
2. Gebre T, Ayele B, Zerihun M et al. (In press) A cluster-randomized clinical trial comparing annual to twice-yearly azithromycin treatment for hyperendemic infectious trachoma in Ethiopia. Lancet.
3. House JI, Ayele B, Porco TC et al. (2009) Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial. Lancet 373, 1111-1118.
4. Keenan JD, Ayele B, Moncada J et al. (2011) RibosomalRNA evidence of ocular Chlamydia trachomatis infection following three annual mass azithromycin distributions in communities with highly prevalent trachoma. Clinical Infectious Diseases. Epub ahead of print. DOI: (accessed 08 February 2012).
5. Melese M, Chidambaram JD, Alemayehu W et al. (2004) Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA 292, 721-725.
6. Nakibinge S, Maher D, Katende J, Kamali A, Grosskurth H & Seeley J (2009) Community engagement in health research: two decades of experience from a research project on HIV in rural Uganda. Tropical Medicine and International Health 14, 190-195.
7. Oliva MS, Munoz B, Lynch M, Mkocha H & West SK (1997) Evaluation of barriers to surgical compliance in the treatment of trichiasis. International Ophthalmology 21, 235-241.
8. Oyejide CO & Fagbami AH (1988) An epidemiological study of rotavirus diarrhoea in a cohort of Nigerian infants: I. Methodology and experiences in the recruitment and follow-up of patients. International Journal of Epidemiology 17, 903-907.
9. Porco TC, Gebre T, Ayele B et al. (2009) Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA 302, 962-968.
10. Rabiu MM & Abiose A (2001) Magnitude of trachoma and barriers to uptake of lid surgery in a rural community of northern Nigeria. Ophthalmic Epidemiology 8, 181-190.
11. Ray KJ, Porco TC, Hong KC et al. (2007) A rationale for continuing mass antibiotic distributions for trachoma. BMC Infectious Diseases 7, 91.
12. Shah NA, House J, Lakew T et al. (2010) Travel and implications for the elimination of trachoma in ethiopia. Ophthalmic Epidemiology 17, 113-117.
13. Solomon A, Zondervan M, Kuper H, Buchan J, Mabey D & Foster A (2006) Trachoma Control: A Guide for Programme Managers. World Health Organization, Geneva.
14. Thylefors B, Dawson CR, Jones BR, West SK & Taylor HR (1987) A simple system for the assessment of trachoma and its complications. Bulletin of the World Health Organization 65, 477-483.
15. West SK, Munoz B, Mkocha H, Gaydos C & Quinn T (2007) Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village. Investigative Ophthalmology & Visual Science 48, 1492-1497.
16. Wright HR, Turner A & Taylor HR (2008) Trachoma. Lancet 371, 1945-1954.
17. Wright HR, Keeffe JE & Taylor HR (2010) Barriers to the implementation of the SAFE strategy to combat hyperendemic trachoma in Australia. Ophthalmic Epidemiology 17, 349-359.
18. Yang JL, Schachter J, Moncada J et al. (2007) Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma. The British Journal of Ophthalmology 91, 293-295.
19. Yang JL, Hong KC, Schachter J et al. (2009) Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification. Investigative Ophthalmology & Visual Science 50, 90-94.